4//SEC Filing
COX CARRIE SMITH 4
Accession 0001453687-25-000016
CIK 0001453687other
Filed
Jan 5, 7:00 PM ET
Accepted
Jan 6, 4:19 PM ET
Size
8.7 KB
Accession
0001453687-25-000016
Insider Transaction Report
Form 4
COX CARRIE SMITH
Director
Transactions
- Award
Stock Option (Right to Buy)
2025-01-02+8,000→ 8,000 totalExercise: $16.93From: 2026-01-02Exp: 2035-01-01→ Common Stock (8,000 underlying) - Award
Common Stock
2025-01-02+2,600→ 15,629 total
Holdings
- 8,266
Stock Option (Right to Buy)
Exercise: $19.66Exp: 2034-01-01→ Common Stock (8,266 underlying)
Footnotes (3)
- [F1]Each Restricted Stock Unit represents a contingent right to receive one share of common stock, which will vest in full on January 2, 2026.
- [F2]On April 4, 2024, the issuer effected a 1-for-30 reverse stock split of its common stock (the "Reverse Stock Split"). The amount of securities reported on this Form 4 have been adjusted to reflect the Reverse Stock Split.
- [F3]This award vests in 36 equal monthly installments following the date of grant, so that it shall be fully vested on January 2, 2027.
Documents
Issuer
Cartesian Therapeutics, Inc.
CIK 0001453687
Entity typeother
IncorporatedNJ
Related Parties
1- filerCIK 0001110753
Filing Metadata
- Form type
- 4
- Filed
- Jan 5, 7:00 PM ET
- Accepted
- Jan 6, 4:19 PM ET
- Size
- 8.7 KB